"R3 Bio has actively pitched 'brainless clones'—cloned human bodies engineered with minimal brain structure—to serve as immunologically perfect organ sources or, ultimately, as hosts for brain transplants in pursuit of radical life extension."
"Despite the evidence gathered by MIT Technology Review, including reports of a 2023 internal letter outlining a technical road map for 'body replacement cloning', R3 Bio denies publicly discussing brainless human clones."
"R3 Bio's relationship with ARPA-H, the US government's Advanced Research Projects Agency for Health, has been described as informal but 'very collaborative', indicating a significant alignment in their goals."
"The company reportedly presented a session titled 'Full Body Replacement' at a high-priced event in Boston, showcasing their ambitious agenda beyond their public persona."
R3 Bio, a Silicon Valley startup, is pursuing the controversial development of brainless cloned human bodies intended for organ sourcing and brain transplantation. While publicly promoting nonsentient monkey organ alternatives, internal investigations reveal a more ambitious agenda involving cloned human bodies with minimal brain structures. The company has garnered significant funding and has connections with the US government's ARPA-H, indicating a collaborative effort towards radical life extension through body replacement cloning.
Read at Silicon Canals
Unable to calculate read time
Collection
[
|
...
]